Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
NeuroVasc Technologies
AddedFeb 15, 2024
UpdatedJun 18, 2026
NeuroVasc Technologies

NeuroVasc Technologies

Series C

NeuroVasc Technologies: Innovating catheter-based solutions for neurovascular diseases.

HQ
Laguna Hills, CA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

NeuroVasc Technologies, founded with the mission to innovate in the field of neurovascular disease treatment, focuses on developing advanced catheter-based technologies. The company aims to enhance patient outcomes through minimally invasive procedures targeting neurovascular conditions such as ischemic stroke. Their flagship product, the NeuroVasc Envi™-SR, is designed for endovascular treatment and is currently undergoing rigorous clinical trials in both the U.S. and China.

Notable figures affiliated with NeuroVasc Technologies include leading experts in neurovascular medicine and seasoned medical device innovators. The company has garnered significant attention and investment from key players in the healthcare industry. A major milestone includes the enrollment of the first patients in their U.S. IDE Clinical Trial and Chinese Pivotal Randomized Controlled Trial, marking critical steps toward regulatory approval and market entry. NeuroVasc Technologies' impact lies in its potential to revolutionize neurovascular treatments, offering new hope for patients suffering from debilitating conditions.

NeuroVasc Technologies - Similar Companies

NeuroVasx logo

NeuroVasx

CereVasc logo

CereVasc

cerevasc.com

Rist Neurovascular logo

Rist Neurovascular

ristneuro.com

NeuRx Medical logo

NeuRx Medical

neurxmed.com

Neurvana Medical logo

Neurvana Medical

Nanovasc logo

Nanovasc

nanovasc.com

Mivi Neuroscience logo

Mivi Neuroscience

mivineuro.com

Scientia Vascular logo

Scientia Vascular

Penumbra logo

Penumbra

penumbrainc.com

Traverse Vascular logo

Traverse Vascular

TheraVasc logo

TheraVasc

Bluegrass Vascular Technologies logo

Bluegrass Vascular Technologies

Progressive Nuero logo

Progressive Nuero

Neuro-Vascular Research & Design logo

Neuro-Vascular Research & Design

Euphrates Vascular logo

Euphrates Vascular

NeuroVasc Technologies - Quick Facts

Who are NeuroVasc Technologies' competitors?

Companies similar to NeuroVasc Technologies include NeuroVasx, CereVasc, Rist Neurovascular and NeuRx Medical.

When was NeuroVasc Technologies founded?

NeuroVasc Technologies was founded in 2015.

Where is NeuroVasc Technologies' headquarters located?

NeuroVasc Technologies' headquarters is located in Laguna Hills, CA, US.

When was NeuroVasc Technologies' last funding round?

NeuroVasc Technologies' most recent funding round was for $34M (USD) in February 2020.

How much has NeuroVasc Technologies raised to-date?

As of Feb 27, 2020, NeuroVasc Technologies has raised a total of $42.8M (USD).

How many employees does NeuroVasc Technologies have?

NeuroVasc Technologies has 19 employees as of Feb 5, 2024.

NeuroVasc Technologies - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Robotics
Geographic Exposure
  • Americas
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified